US-China Joint Commission on Commerce and Trade
Medical Device and Pharmaceutical Subgroup
Pharmaceutical Task Force
April 11-12, 2005
The U.S. - China Joint Commission on Commerce and Trade (JCCT) Medical Devices and
Pharmaceuticals Subgroup meeting was held in Washington, D.C. on April 11-12, 2005.
The Subgroup opened with a plenary session that included all participants on both the
Medical Device and Pharmaceutical Task Forces. Each of the Task Forces then pursued
separate tracks until a joint discussion on In Vitro Diagnostics (IVDs) and the U.S.- China
Health Care Forum reunited them.
Brief self introductory presentations were made by the trade organizations present during
the Pharmaceutical Task Force. In attendance were Biotechnology Industry Association
(BIO), Consumer Healthcare Products Association (CHPA), Generics Pharmaceutical
Association (GPhA), Pharmaceutical Research and Manufacturers of America (PhRMA),
Plasma Protein Therapeutics Association (PPTA), Pharmaceut ical Security Institute (PSI),
U.S. Pharmacopoeia (USP), Regulatory Affairs Professionals Society (RAPS).
The meeting concluded with a joint plenary session in conjunction with the Medical Device
Task Force and the signing of a new Work Plan. The next Pharmaceutical Task Force
meeting will be in August 2005, in Beijing.
Opening Plenary Session
Deputy Under Secretary Timothy Hauser opened the Subgroup with remarks welcoming
the Chinese State Food and Drug Administration delegation and expressing Commerce’s
appreciation to U.S. industry associations for their participation. Joseph Bogosian, Deputy
Assistant Secretary for Manufacturing, who is the U.S. Co-chair of the Subgroup, noted
the Subgroup’s ambitious agenda, and emphasized the importance of these face to face
meetings. DAS Bogosian also discussed the recent ITA reorganization, and how it would
benefit the Subgroup. He also emphasized that the Subgroup meeting was an excellent
opportunity to learn about change